ProCE Banner Activity

BELIEVE Subanalysis: Evaluation of Responders With Transfusion-Dependent β-Thalassemia to Luspatercept

Slideset Download
Conference Coverage
This ad hoc analysis found durable responses and multiple episodes of clinically meaningful reductions in transfusion dependence among patients with β-thalassemia receiving luspatercept.

Released: December 17, 2019

Expiration: December 15, 2020

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Celgene

Dova Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Loxo Oncology subsidiary of Eli Lilly

Pharmacyclics an AbbVie Company